Ro's tirzepatide program bills membership and medication separately. Expect $299–$449 monthly for Zepbound plus $149 monthly membership, or $373–$598 effective monthly combined—higher than compounded alternatives.

SlimDownRx locks you into prepaid bundles with no documented month-to-month option. This guide walks through the timing, clinical intake, and cost considerations when switching to PlexusDx's flexible tirzepatide program.

Big Easy's 12-week prepaid model offers lower effective monthly rates, but PlexusDx bills predictably month-to-month with no upfront commitment. Here's how to transfer your prescription and compare the real cost difference before you switch.

Henry Meds and Eden both offer compounded semaglutide and tirzepatide in oral and injectable forms, but billing structures, month-to-month rates, and all-in costs differ substantially.

Belle Health offers lower per-month rates on six-month prepay plans, while PlexusDx undercuts Belle on semaglutide month-to-month and eliminates upfront payment.

PlexusDx charges $289/month for tirzepatide injection on a month-to-month plan; ShedRx charges $299/month monthly or $239/month on a 12-month commitment. This comparison examines pricing structure, medication routes, and commitment flexibility across both telehealth providers.

We compare month-to-month and prepaid rates for injectable tirzepatide across six providers—Eden, Embody, Found, Peak Wellness, TrimRx, and PlexusDx—using standard ongoing rates and prepaid totals verified in July–August 2026.

The best tirzepatide online in 2026 depends on insurance status, format, and whether you want a genetic baseline guiding titration. Compare MEDVi, YUCCA Health, Willow, Eden, and TrimRx against PlexusDx Tirzepatide Injection ($289/mo) and Tirzepatide Oral ($349/mo), with the optional Precision Peptide Genetic Test for pathway-level context.

Medicare Part D is statutorily prohibited from covering GLP-1s prescribed solely for weight loss, and manufacturer copay cards are off-limits to Medicare beneficiaries. This guide explains the Medicare GLP-1 Bridge launching July 2026, Part D backdoors for diabetes, CVD, and OSA, and the cash-pay options that work today — including PlexusDx Microdose GLP-1 Protocol at $129/mo flat and Semaglutide Injection at $189/mo month-to-month, or from $149/mo on the 6-month plan.